Investors
Zalgen is a privately held company, and not currently seeking outside investment. However, as a rapidly expanding biopharmaceutical business leading the way in Lassa fever products and research, we are always receptive to entertaining confidential discussions regarding collaborations and alliances which may potentially include strategic investment. To learn more, contact Dr. Luis Branco, Zalgen Managing Director and Co-Founder at lbranco@zalgenlabs.com.
